PH31052A - Steroid derivatives for the treatment of prostatichyperthropy their preparation and uses. - Google Patents

Steroid derivatives for the treatment of prostatichyperthropy their preparation and uses.

Info

Publication number
PH31052A
PH31052A PH46066A PH46066A PH31052A PH 31052 A PH31052 A PH 31052A PH 46066 A PH46066 A PH 46066A PH 46066 A PH46066 A PH 46066A PH 31052 A PH31052 A PH 31052A
Authority
PH
Philippines
Prior art keywords
substituted alkyl
treatment
alkyl
prostatichyperthropy
preparation
Prior art date
Application number
PH46066A
Other languages
English (en)
Inventor
Kojima Koichi
Kurata Hitoshi
Ishibashi Koki
Horikoshi Hiroyahi
Hamada Takakazu
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of PH31052A publication Critical patent/PH31052A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH46066A 1992-04-20 1993-04-19 Steroid derivatives for the treatment of prostatichyperthropy their preparation and uses. PH31052A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9981692 1992-04-20
JP32804392 1992-12-08

Publications (1)

Publication Number Publication Date
PH31052A true PH31052A (en) 1998-02-03

Family

ID=26440917

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46066A PH31052A (en) 1992-04-20 1993-04-19 Steroid derivatives for the treatment of prostatichyperthropy their preparation and uses.

Country Status (25)

Country Link
US (3) US5536714A (xx)
EP (2) EP0567271B1 (xx)
JP (1) JP2514778B2 (xx)
KR (1) KR0146680B1 (xx)
CN (2) CN1041095C (xx)
AT (1) ATE154937T1 (xx)
AU (1) AU656852B2 (xx)
CA (1) CA2094300C (xx)
CZ (2) CZ283791B6 (xx)
DE (1) DE69311837T2 (xx)
DK (1) DK0567271T3 (xx)
ES (1) ES2105108T3 (xx)
FI (1) FI931765A (xx)
GR (1) GR3024896T3 (xx)
HK (1) HK1000303A1 (xx)
HU (1) HU219579B (xx)
ID (1) ID18576A (xx)
IL (1) IL105478A (xx)
MX (1) MX9302300A (xx)
NO (1) NO304891B1 (xx)
NZ (1) NZ247449A (xx)
PH (1) PH31052A (xx)
RU (2) RU2114861C1 (xx)
TW (2) TW401420B (xx)
ZA (1) ZA932732B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1259419B (it) * 1991-05-24 1996-03-18 Erba Carlo Spa Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
JPH07506363A (ja) * 1992-04-30 1995-07-13 スミスクライン・ビーチャム・コーポレイション １７αおよび１７β−置換のエストラ−１，３，５（１０）−トリエン−３−カルボン酸
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
GB9224148D0 (en) * 1992-11-18 1993-01-06 Smithkline Beecham Corp Compounds
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
CN1133005A (zh) * 1993-09-03 1996-10-09 史密丝克莱恩比彻姆公司 稳定的片剂
GB9324371D0 (en) * 1993-11-26 1994-01-12 Erba Carlo Spa Side chain fluoro substituted 3-carboxysteroids
GB9411103D0 (en) * 1994-06-03 1994-07-27 Smithkline Beecham Corp Compounds
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
US7258850B2 (en) * 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
CA2462456C (en) * 2001-10-03 2010-05-04 Merck & Co., Inc. Androstane 17-beta-carboxamides as androgen receptor modulators
AU2002361861A1 (en) * 2001-12-21 2003-07-30 Rhode Island Hospital SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
US20060148725A1 (en) * 2001-12-21 2006-07-06 The Miriam Hospital Selective 11beta HSD inhibitors and methods of use thereof
EP1624876A2 (en) * 2003-04-29 2006-02-15 The Miriam Hospital Selective testicular 11beta-hsd inhibitors and methods of use thereof
AU2006239221C1 (en) 2005-04-28 2012-08-16 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
US7604386B2 (en) * 2005-11-18 2009-10-20 Federal-Mogul World Wide, Inc Lamp assembly having a socket made from high temperature plastic
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US8563728B2 (en) * 2009-07-09 2013-10-22 Aurobindo Pharma Ltd. Process for the preparation of Dutasteride
CN111362999B (zh) * 2020-03-16 2022-03-29 江苏联环药业股份有限公司 一种爱普列特杂质及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527030B2 (en) * 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
IL74365A (en) * 1984-02-27 1990-07-26 Merck & Co Inc 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5137882A (en) * 1990-06-11 1992-08-11 Holt Dennis A Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
WO1992018132A1 (en) * 1991-04-17 1992-10-29 Merck & Co., Inc. Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor
US5196411A (en) * 1991-08-16 1993-03-23 Merck & Co., Inc. 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors

Also Published As

Publication number Publication date
NZ247449A (en) 1995-02-24
CZ90097A3 (cs) 1998-07-15
MX9302300A (es) 1994-03-31
KR930021654A (ko) 1993-11-22
RU2114861C1 (ru) 1998-07-10
RU95101838A (ru) 1997-01-10
IL105478A (en) 1998-03-10
RU2097387C1 (ru) 1997-11-27
FI931765A (fi) 1993-10-21
CA2094300A1 (en) 1993-10-21
ATE154937T1 (de) 1997-07-15
EP0725074A2 (en) 1996-08-07
EP0567271B1 (en) 1997-07-02
US5717088A (en) 1998-02-10
HU219579B (hu) 2001-05-28
EP0725074A3 (en) 1996-11-20
HUT64558A (en) 1994-01-28
JPH06279487A (ja) 1994-10-04
CN1195666A (zh) 1998-10-14
GR3024896T3 (en) 1998-01-30
NO304891B1 (no) 1999-03-01
NO931401D0 (no) 1993-04-16
EP0567271A3 (en) 1994-11-23
NO931401L (no) 1993-10-21
DE69311837D1 (de) 1997-08-07
TW401420B (en) 2000-08-11
IL105478A0 (en) 1993-08-18
AU656852B2 (en) 1995-02-16
CA2094300C (en) 2003-01-28
ES2105108T3 (es) 1997-10-16
US5536714A (en) 1996-07-16
CZ67893A3 (en) 1994-01-19
DK0567271T3 (da) 1998-02-16
CN1083070A (zh) 1994-03-02
EP0567271A2 (en) 1993-10-27
HU9301155D0 (en) 1993-07-28
CZ284206B6 (cs) 1998-09-16
ZA932732B (en) 1993-10-28
CN1041095C (zh) 1998-12-09
CZ283791B6 (cs) 1998-06-17
FI931765A0 (fi) 1993-04-19
AU3698493A (en) 1993-10-21
ID18576A (id) 1998-04-23
DE69311837T2 (de) 1998-02-12
US5760025A (en) 1998-06-02
TW238312B (xx) 1995-01-11
JP2514778B2 (ja) 1996-07-10
HK1000303A1 (en) 1998-02-20
KR0146680B1 (ko) 1998-08-01

Similar Documents

Publication Publication Date Title
HK1000303A1 (en) Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses
AU8682191A (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
EP1175208A4 (en) COMPOSITION FOR PREVENTION OR TREATMENT OF DEMENTIA CONTAINING A HYDROXYCINNAMIC ACID DERIVATIVE OR AN EXTRACT OF AN ANGELICAE SPECIES CONTAINING SAID ACID
ES8306373A1 (es) "procedimiento para la preparacion de 9-(2-(3-indolil)-etil)-1-oxa-4,9-diazaspiro (5.5) undecan-3-onas".
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
UA66888C2 (uk) 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
AU2287499A (en) Azetidinecarboxamide derivatives for treating cns disorders
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
AU2178099A (en) Azetidinecarboxamide derivatives for treating cns disorders
AU6101890A (en) Therapeutic agents for the treatment of peptic ulcer disease
AU2178199A (en) Azetidinecarboxamide derivatives for the treatment of cns disorders
HUT47923A (en) Process for production of new derivatives of naphtotiazephin and medical compositions containing these substances